3 ms·

It seems almost certain with the dawning age of biotechnology right around the corner that private options are going to completely dominate any public options c

• mindslight 7y ago
  Private services may provide treatment with amazing outcomes, but that doesn't necessarily mean that private payment plans will be needed to financialize those costs. As a well-off individual, why would you want to give a bunch of money to a company with the same eventual dynamic wherein they decide to not cover the specific treatment you eventually need? As an insurer, why would you want to be in the position of customers expecting you cover unknown unknowns? If you're aiming to cover boutique treatments, then your risk model becomes what expensive new treatments are invented! Furthermore, once you're talking about that kind of market, there's no need to bundle everything into a single plan. Rather there is a baseline of modern medicine that can be predictably provided (however that is), and then people with more resources can direct paying for hopeful emerging treatments.